bpc 157 perimenopause BPC-157 – 10MG – MOB Biotech A Federal Advisory Panel Just

For external use only

Research demonstrates that BPC-157 naturally travels to areas of tissue damage throughout the body

Who Should Avoid Peptide Therapy The following patient profiles are not appropriate candidates for peptide therapy, based on contraindication guidance from Bonza Health and Stem Cell MIA: Current or recent cancer diagnosis: Peptides that elevate IGF-1 or activate angiogenesis pathways present an unacceptable theoretical risk in individuals with active or recently treated malignancy

Understanding these biological rhythms is fundamental to developing an optimal dosing strategy

The safest route is a medical clinic that prescribes compounded BPC-157 from a licensed US pharmacy and supervises the protocol

First: What Governs Compounding Pharmacies